Armada and Edarat Group Announce Partnership to Bring Edge Computing and Artificial Intelligence to Middle East and North Africa’s Industrial Sector

IYADH, Saudi Arabia Armada, an edge computing pioneer redefining the future of connectivity, compute, and AI, today announced a strategic collaboration with Edarat Group, a leader in Data Center engineering consulting and Cloud Services in Middle East and North Africa (MENA) region. Together, Armada and Edarat Group will unlock forContinue Reading

تألق شركات كوريا الجنوبية في معرض إكسباند نورث ستار 2023 في دبي

DUBAI — At the recent Expand North Star Dubai 2023, the K-Metaverse Pavilion took center stage, underscoring its significance in the metaverse domain. Featuring eight meticulously selected companies, the pavilion highlighted firms poised to elevate South Korea’s metaverse industry to global prominence. The K-Metaverse Pavilion is emblematic of NIPA’s commitmentContinue Reading

BeiGene Expands Presence in Middle East and North Africa Region with Opening of United Arab Emirates Office

Dubai, United Arab Emirates BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the first step in the company’s expansion in the Middle East and North Africa (MENA) region with the formal opening of its office in Dubai,Continue Reading

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with CanariaBio, a Korean biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer. Under the terms of the agreement, Hikma has an exclusive license to commercialise Oregovomab in 18Continue Reading

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with Cassiopea S.p.A., a subsidiary of Cosmo Pharmaceuticals N.V. (Cosmo). Cosmo is focused on developing and commercialising products to treat selected gastrointestinal diseases and dermatological conditions. Under the terms of the agreement, Hikma hasContinue Reading

Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa

Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new strategic partnership and exclusive licensing agreement with SK Biopharmaceuticals, a global biotech company focused on the development of treatments for central nervous system (CNS) disorders and oncology, for the Middle East and North Africa (MENA). UnderContinue Reading

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and commercialisation agreement with Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercialising precision, cell targeting therapies based on its proprietary Alluminox™ platform. Under the terms of the agreement, Hikma hasContinue Reading

شركة UWN الإمارات تنطلق في الشرق الأوسط وشمال أفريقيا وتفتتح مكتباً لها في دبي

Dubai, March 2022: A new and progressive sports entertainment company has launched in the Middle East and North Africa and opened their office in Dubai recently. UWN or United Wrestling Nation is a sports management company headed by some of the most experienced business, strategy, finance, and sports entertainment professional.Continue Reading